229 related articles for article (PubMed ID: 7897364)
21. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
Marinos G; Smith HM; Naoumov NV; Williams R
Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
Fei GZ; Sylvan SP; Hellström UB; Yao GB
J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
[TBL] [Abstract][Full Text] [Related]
23. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
25. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.
Tong SP; Li JS; Vitvitski L; Trépo C
Virology; 1990 Jun; 176(2):596-603. PubMed ID: 2345966
[TBL] [Abstract][Full Text] [Related]
26. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
28. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
29. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
30. Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha.
Brunetto MR; Oliveri F; Colombatto P; Capalbo M; Barbera C; Bonino F
J Hepatol; 1995; 22(1 Suppl):42-4. PubMed ID: 7602075
[TBL] [Abstract][Full Text] [Related]
31. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection.
Wakita T; Kakumu S; Yoshioka K; Ishikawa T; Ito Y; Shinagawa T
Digestion; 1992; 52(1):26-33. PubMed ID: 1426694
[TBL] [Abstract][Full Text] [Related]
32. HBV pre-core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood.
Colombatto P; Barbera C; Bortolotti F; Maina AM; Moriconi F; Cavallone D; Calvo P; Oliveri F; Bonino F; Brunetto MR
J Med Virol; 2018 Jul; 90(7):1232-1239. PubMed ID: 29488227
[TBL] [Abstract][Full Text] [Related]
33. High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B.
Norder H; Brattström C; Magnius L
J Med Virol; 1989 Apr; 27(4):322-8. PubMed ID: 2656911
[TBL] [Abstract][Full Text] [Related]
34. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
[TBL] [Abstract][Full Text] [Related]
35. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
36. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus precore/core variation and interferon therapy.
Fattovich G; McIntyre G; Thursz M; Colman K; Giuliano G; Alberti A; Thomas HC; Carman WF
Hepatology; 1995 Nov; 22(5):1355-62. PubMed ID: 7590647
[TBL] [Abstract][Full Text] [Related]
39. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
Sonneveld MJ; Rijckborst V; Zeuzem S; Heathcote EJ; Simon K; Senturk H; Pas SD; Hansen BE; Janssen HL
Hepatology; 2012 Jul; 56(1):67-75. PubMed ID: 22307831
[TBL] [Abstract][Full Text] [Related]
40. Southern hybridisation analysis of HBV DNA in peripheral blood leucocytes and of different cell types: changes during the natural history and with interferon-alpha therapy in patients with hepatitis B virus infection.
Catterall AP; Murray-Lyon IM; Zuckerman AJ; Harrison TJ
J Med Virol; 1994 Jul; 43(3):269-75. PubMed ID: 7931189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
